News
1h
New Vision on MSNWHO recommends Uganda-tested HIV prevention drug, issues guidelines on usageThe recommendation comes just weeks after the US Food and Drug Administration (FDA) approved the drug for use. Lenacapavir trials were conducted in Uganda and South Africa and demonstrated 100% ...
WHO endorses biannual injectable Lenacapavir for HIV prevention. This long-acting PrEP offers hope for high-risk groups and ...
It is common knowledge that cross-border trade has a direct impact on Nigeria’s economic development, especially with the ...
Nigeria’s women’s team, led by Ajoke Ojomu, maintained regional dominance, defeating Benin Republic, Ghana, and Guinea to retain their title. 222 ...
2hOpinion
The New Times on MSNRwanda’s new line of defence on the battlefield is economic influenceRwanda’s doctrine of national defense has been anchored in discipline, preparedness, and a capable military force that has ...
The WHO has approved the use of a new drug to prevent HIV. The drug is called Lenacapavir, and what makes it unique is that ...
Nigeria clinched gold medals in both men's and women's International Table Tennis Federation (ITTF) West Africa Regional ...
Mu Irushanwa rya Billie Jean King Cup 2025, Umutoza w’Ikipe y’Igihugu, Rutikanga Sylvain, yitabaje abakinnyi bane ...
Long-acting injectable PrEP may improve access, protection and adherence, especially for young people and pregnant women, according to Hasina Subedar, a senior technical advisor at South Africa’s ...
The Democratic Republic of the Congo (DR Congo) has agreed to pay more than $46.37m in a sponsorship deal with Spanish ...
Results from the Phase III PURPOSE 1 (NCT04994509) and PURPOSE 2 (NCT04925752) trials highlight Yeztugo’s (lenacapavir) ...
Orion Resource Partners and Virtus Minerals are jointly negotiating the purchase of Chemaf, Bloomberg sources say.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results